Wilfried Mutombo Kalonji

Statistics

Publications

Citations

459

H-Index

Active since

2017

Affiliations

University of Bandundu(Current)

Kinshasa General Hospital

Swiss Tropical and Public Health Institute

Drugs for Neglected Diseases Initiative

Ministry of Public Health

Wilfried Mutombo Kalonji is an author at University of Bandundu specializing in protozoal infections, treatment of trypanosomiasis, and infectious diseases.

Publications per year

2017–2022

Publications

Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial

Victor Kande Betu Ku Mesu, Wilfried Mutombo Kalonji, Clélia Bardonneau et al. · The Lancet · 2017 · 269 citations

Veterinary Medicine, Biology, Infectious Diseases +15

Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2/3 trial

Victor Kande Betu Kumeso, Wilfried Mutombo Kalonji, Sandra Rembry et al. · The Lancet Infectious Diseases · 2022 · 116 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +17

Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study

Victor Kande Betu Ku Mesu, Wilfried Mutombo Kalonji, Clélia Bardonneau et al. · The Lancet Global Health · 2021 · 56 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +16

Safety and efficacy of oral fexinidazole in children with gambiense human African trypanosomiasis: a multicentre, single-arm, open-label, phase 2–3 trial

Victor Kande Betu Kumeso, Wilfried Mutombo Kalonji, Clélia Bardonneau et al. · The Lancet Global Health · 2022 · 18 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +15

1–4 of 4